Osteonecrosis

M13_OSTEONECROSIS

osteonecrosis: A none disease characterized by death of bone tissue due to a lack of blood supply.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M87 Hospital discharge: ICD-9 — 7334 Cause of death: ICD-10 — M87 Cause of death: ICD-9 — 7334 2 out of 7 registries used, show all original rules.	2125
4. Check minimum number of events None	2125
5. Include endpoints None	2125
6. Filter based on genotype QC (FinnGen only)	2125

Control definitions (FinnGen only)

Control exclude: M13_OSTEOCHONDRO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M86-M90
Name in latin: Osteonecrosis

NAME	M13_OSTEONECROSIS
CONTROL_EXCLUDE	M13_OSTEOCHONDRO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M87
HD_ICD_9	7334
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M87
COD_ICD_9	7334
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Osteonecrosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Osteonecrosis due to drugs

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11327	6119	5165
Only index persons	10640	5800	4840
Unadjusted period prevalence (%)
Whole population	0.16	0.18	0.14
Only index persons	0.20	0.21	0.18
Median age at first event (years)
Whole population	61.28	64.60	57.35
Only index persons	61.13	64.33	57.29

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2125	1180	945
Unadjusted period prevalence (%)	0.41	0.40	0.42
Median age at first event (years)	62.16	62.57	61.66

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1861: Matched controls
18611

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

+∞

323.0

370

M87.0

ICD-10 Finland

Idiopathic aseptic necrosis of bone

4338.0

323.0

817

M87.9

ICD-10 Finland

Osteonecrosis, unspecified

3858.7

323.0

574

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

10.1

228.4

498

650

M16.1

ICD-10 Finland

Other primary coxarthrosis

6.8

202.3

589

1184

NF1AA

NOMESCO Finland

Hip X-ray examination

7.9

186.3

475

778

NE1AA

NOMESCO Finland

Pelvis X-ray examination

9.0

168.9

387

527

M87.3

ICD-10 Finland

Other secondary osteonecrosis

+∞

144.7

137

B01AB05

ATC

enoxaparin; parenteral

3.6

139.7

898

3800

M05BX04

ATC

denosumab; parenteral

10.7

135.9

277

299

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.2

114.2

887

4135

N02AA05

ATC

oxycodone; systemic

4.3

114.2

501

1472

WX320

NOMESCO Finland

Spinalanesthesy

3.5

111.9

682

2646

N02AX02

ATC

tramadol; systemic, rectal

3.0

109.9

1057

5656

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

3.0

104.8

987

5145

L13

ICPC

Hip symptom/complaint

3.8

104.1

532

1773

M87.8

ICD-10 Finland

Other osteonecrosis

+∞

103.1

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

9.0

100.1

223

277

M87.2

ICD-10 Finland

Osteonecrosis due to previous trauma

+∞

94.6

M16.7

ICD-10 Finland

Other secondary coxarthrosis

35.9

91.1

118

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

9.9

86.2

181

201

N02AJ06

ATC

codeine and paracetamol; systemic

2.7

85.5

901

4817

R4110

NOMESCO Finland

Physiotherapy

2.8

82.0

700

3274

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.0

81.8

373

1098

N02BE01

ATC

paracetamol; systemic, rectal

4.1

79.5

1721

13929

WX002

NOMESCO Finland

Sedation and analgesia

3.0

76.0

552

2307

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

4.8

75.8

276

650

ECB20

NOMESCO Finland

Oral alveoplasty

21.4

74.4

111

N03AX16

ATC

pregabalin; oral

2.8

72.6

614

2812

ZXA00

NOMESCO Finland

Right side

2.6

69.0

682

3398

M25.5

ICD-10 Finland

Pain in joint

2.5

64.9

670

3391

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

5.2

64.1

214

455

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.4

63.3

756

4119

A02BC02

ATC

pantoprazole; systemic

2.4

63.3

1344

9699

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

11.3

63.1

122

115

H02AB06

ATC

prednisolone; systemic

2.3

62.7

993

6209

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

62.7

513

2265

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

61.7

961

5942

C03CA01

ATC

furosemide; systemic

2.5

61.1

638

3228

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.8

61.0

289

863

ZXA05

NOMESCO Finland

Left side

2.5

60.9

623

3114

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.2

58.1

997

6378

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

9.5

57.2

121

135

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

3.2

56.2

338

1211

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.4

55.5

307

1033

M79.6

ICD-10 Finland

Pain in limb

2.2

55.1

772

4464

N03AX12

ATC

gabapentin; oral

2.8

54.7

407

1677

ZX120

NOMESCO Finland

Intravenous

3.5

54.6

282

899

L89

ICPC

Osteoarthrosis of hip

5.9

54.3

161

296

L28

ICPC

Limited function/disability (L)

2.8

53.6

399

1642

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

6.6

53.5

143

230

S18

ICPC

Laceration/cut

2.1

50.9

883

5554

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

5.9

50.7

149

271

X59

ICD-10 Finland

Exposure to unspecified factor

2.6

50.7

441

1983

WF049

NOMESCO Finland

Radiotherapy of metastasis

6.1

50.6

144

251

M05BA04

ATC

alendronic acid; oral

3.8

47.4

216

618

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

4.8

47.3

168

379

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

5.1

46.6

156

330

H02AB02

ATC

dexamethasone; systemic

3.0

46.3

300

1118

M01AH05

ATC

etoricoxib; oral

2.0

46.3

1181

8563

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

10.8

45.9

SAA03

NOMESCO Finland

Extended examination of mouth

2.1

45.9

770

4706

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.0

45.4

193

518

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.2

44.7

266

934

A28

ICPC

Limited function/disability NOS

2.7

44.4

350

1473

NF1DA

NOMESCO Finland

X-ray of hips

7.4

44.2

109

156

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

53.4

43.8

163

Kela drug reimbursment

Abiraterone and enzalutamide

15.1

43.6

WX110

NOMESCO Finland

Local anesthesy

2.0

43.3

1310

10015

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

43.1

608

3429

M81.9

ICD-10 Finland

Osteoporosis, unspecified

8.3

42.7

122

SAA02

NOMESCO Finland

Basic examination of mouth

2.0

41.9

1192

8834

L04AA06

ATC

mycophenolic acid; systemic

8.5

41.6

114

127

Kela drug reimbursment

Transplant complication

9.2

40.4

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

4.8

40.1

141

314

J01FF01

ATC

clindamycin; systemic

2.1

39.7

585

3336

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

39.2

375

1745

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

38.5

469

2454

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

10.5

38.4

B01AF01

ATC

rivaroxaban; oral

2.6

38.3

311

1322

XW000

NOMESCO Finland

Bone marrow biopsy

4.7

37.9

136

309

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

7.5

36.3

123

C90.0

ICD-10 Finland

Multiple myeloma

12.7

35.6

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

34.7

304

1342

153

Kela drug reimbursment

Lenalidomid

20.9

34.5

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

7.3

34.3

119

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.5

34.3

127

298

JN4BD

NOMESCO Finland

Extensive body CT

2.6

34.2

274

1152

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.1

34.1

138

353

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.7

34.0

266

1101

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

33.5

441

2365

M48.0

ICD-10 Finland

Spinal stenosis

2.5

33.2

284

1235

L02BB04

ATC

enzalutamide; oral

14.0

33.1

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

32.9

558

3318

K10.20

ICD-10 Finland

Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)

45.3

32.9

A04AA01

ATC

ondansetron; systemic, rectal

3.2

32.8

185

620

R50.9

ICD-10 Finland

Fever, unspecified

2.4

32.8

303

1374

A46

ICD-10 Finland

Erysipelas

2.4

32.8

317

1470

L04AX04

ATC

lenalidomide; oral

21.4

32.7

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.4

32.5

167

523

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.4

32.4

170

540

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.9

32.4

209

769

L03AA02

ATC

filgrastim; parenteral

5.2

32.4

104

210

EDW99

NOMESCO Finland

Other operation on mandible

89.2

31.8

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

7.0

31.7

119

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.0

31.4

465

2611

L04AA01

ATC

[U] ciclosporin; systemic

8.8

31.3

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

31.2

323

1549

J01DB01

ATC

cefalexin; oral

2.0

30.9

1524

12919

K10.21

ICD-10 Finland

Osteoradionecrosis of jaw (acute)(chronic)(suppurative)

47.1

30.7

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

4.6

30.4

110

252

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

30.2

552

3353

L15

ICPC

Knee symptom/complaint

2.0

30.2

438

2433

H02AB07

ATC

prednisone; oral

2.3

29.7

309

1482

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

15.9

29.5

352

Kela drug reimbursment

Abiraterone and enzalutamide

16.6

29.4

N05CF01

ATC

zopiclone; oral

1.8

29.4

634

4078

L04AD01

ATC

ciclosporin; systemic

7.0

29.3

110

D64.9

ICD-10 Finland

Anaemia, unspecified

2.7

29.2

223

907

WZA90

NOMESCO Finland

Other doctors statement

2.0

29.2

458

2621

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.5

29.1

240

1021

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

28.8

568

3536

R60.0

ICD-10 Finland

Localized oedema

2.5

28.7

257

1141

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

7.1

28.5

104

JN4AD

NOMESCO Finland

Body CT examination

2.9

28.4

190

712

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

28.3

360

1885

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.0

28.3

173

612

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

28.2

434

2460

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

28.0

160

540

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.9

28.0

204

318

Kela drug reimbursment

Teriparatide

65.0

28.0

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

3.5

28.0

135

402

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.0

27.9

174

624

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

10.5

27.5

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

27.5

182

678

5BA08

NOMESCO Finland

14.7

27.5

M05BA07

ATC

risedronic acid; oral

4.9

27.3

196

L02BX03

ATC

abiraterone; oral

13.7

27.3

EBA00

NOMESCO Finland

Extraction of tooth

1.8

27.3

614

3981

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

27.3

335

1728

H02AB04

ATC

methylprednisolone; systemic

2.2

27.2

314

1574

H02AB09

ATC

hydrocortisone; systemic

6.2

26.9

124

B01AB10

ATC

tinzaparin; parenteral

2.9

26.9

172

625

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

13.8

26.8

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

16.3

26.8

ZX112

NOMESCO Finland

Subcutaneous

5.6

26.7

145

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.8

26.6

179

673

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

7.9

26.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

26.2

909

6706

K10.25

ICD-10 Finland

Sequences of jawbones

21.5

26.1

L04AX01

ATC

azathioprine; systemic

3.8

26.0

115

318

Z51.5

ICD-10 Finland

Palliative care

3.1

25.7

148

503

329

Kela drug reimbursment

Lenalidomide

22.2

25.7

NFK99

NOMESCO Finland

Other operation on bone of femur

136.9

25.7

WW500

NOMESCO Finland

Blood transfusion

3.8

25.5

113

314

N06AX21

ATC

duloxetine; oral

2.4

25.4

229

1019

J01MA12

ATC

levofloxacin; systemic

2.0

25.4

371

2053

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

5.7

25.3

134

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

25.3

999

7608

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

10.7

25.3

M16.6

ICD-10 Finland

Other secondary coxarthrosis, bilateral

36.1

25.2

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

25.1

229

1024

M87

ICD-10 Finland

Osteonecrosis

+∞

25.0

H05AA02

ATC

teriparatide; parenteral

58.8

25.0

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.5

24.9

211

N06AX11

ATC

mirtazapine; oral

1.8

24.9

594

3900

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.9

24.8

104

275

EDA10

NOMESCO Finland

Biopsy of mandible

32.5

24.7

NFB60

NOMESCO Finland

Demanding prosthetic replacement of hip

16.6

24.5

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.0

24.5

149

523

L95

ICPC

Osteoporosis

5.1

24.3

158

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.3

24.0

128

411

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.3

23.6

247

1181

Z71.8

ICD-10 Finland

Other specified counselling

1.9

23.5

432

2589

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.2

23.3

144

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

6.8

23.3

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.3

23.3

239

1129

WX290

NOMESCO Finland

Other blockade of nerve

1.7

23.2

744

5302

L02BX02

ATC

degarelix; parenteral

8.4

23.2

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.5

23.1

200

867

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

7.9

23.1

M19.2

ICD-10 Finland

Other secondary arthrosis

7.9

23.1

L17

ICPC

Foot/toe symptom/complaint

1.8

23.0

489

3078

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

65.8

22.9

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

12.7

22.6

A02BC05

ATC

esomeprazole; systemic

1.7

22.5

765

5529

WX402

NOMESCO Finland

General anaesthesia

2.0

22.4

327

1797

M17.5

ICD-10 Finland

Other secondary gonarthrosis

6.9

22.4

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

22.3

1237

10172

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.4

22.2

113

351

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.7

22.2

157

607

M01AH01

ATC

celecoxib; oral (coxibs)

1.9

22.1

372

2157

WW200

NOMESCO Finland

Immunization

4.2

22.1

208

7334B

ICD-9 Finland

Other disorders of bone and cartilage, Aseptic necrosis of bone[NECROSIS ASEPTICA CAPITIS ET COLLI FEMORIS]

+∞

21.9

S97

ICPC

Chronic ulcer skin

3.0

21.8

130

451

116

Kela drug reimbursment

Prostate cancer

3.1

21.6

123

414

WZC30

NOMESCO Finland

Teaching

2.1

21.5

271

1403

Y77

ICPC

Malignant neoplasm prostate

4.5

21.4

181

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

21.3

173

727

L02BB03

ATC

bicalutamide; oral

4.6

21.2

169

J01MA02

ATC

ciprofloxacin; systemic

1.6

21.2

704

5029

NF3AA

NOMESCO Finland

Femur X-ray examination

6.6

21.2

EBA10

NOMESCO Finland

Surgical removal of tooth

2.3

21.1

206

951

TQW40

NOMESCO Finland

Remowal of suture of skin

2.6

21.1

156

622

192

Kela drug reimbursment

Fulvestrant

11.4

21.0

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

3.6

20.9

275

L02BA03

ATC

fulvestrant; parenteral

10.7

20.9

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.8

20.8

240

B01AB04

ATC

dalteparin; parenteral

3.1

20.7

120

410

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

6.8

20.7

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

20.7

478

3072

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

212.2

20.6

R06.0

ICD-10 Finland

Dyspnoea

1.8

20.5

455

2885

K05.31

ICD-10 Finland

Periodontitis pronounced

2.2

20.4

216

1034

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

20.4

263

1373

A07AA02

ATC

nystatin; oral

2.7

20.1

145

568

Z01.2

ICD-10 Finland

Dental examination

1.6

20.1

715

5181

EDB00

NOMESCO Finland

Partial excision of mandible

27.4

20.0

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

3.5

20.0

285

J01MA14

ATC

moxifloxacin; systemic

2.4

20.0

184

823

A06AD11

ATC

lactulose; oral

2.0

19.9

275

1477

Z94.0

ICD-10 Finland

Kidney transplant status

7.3

19.6

WX212

NOMESCO Finland

Femoral plexus blockade

5.7

19.5

100

A04AA02

ATC

granisetron; systemic, transdermal

2.5

19.5

155

641

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

19.5

212

1027

B03XA02

ATC

darbepoetin alfa; parenteral

5.5

19.4

109

M16.5

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

664

2479

3.44

139.34

3.1

2.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1371

8361

2.80

110.61

6.0

4.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

533

1980

3.26

109.75

6.6

4.3

u/l

240.4

246.2

0.29

512

1878

(3023368) Bacteria identified in Blood by Culture

946

4835

2.72

107.94

7.1

4.2

—

(42870588) Differential panel, method unspecified - Blood

1087

6037

2.64

103.61

10.5

5.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1552

10314

2.87

101.95

19.9

8.9

e9/l

4.2

4.1

1.20

1382

8976

(3001604) Monocytes [#/volume] in Blood

1393

8792

2.70

100.96

11.0

5.6

e9/l

0.6

2.20

1217

7551

(3006315) Basophils [#/volume] in Blood

1393

8833

2.68

99.28

11.0

5.6

e9/l

0.0

0.90

1219

7591

(3019069) Monocytes/100 leukocytes in Blood

1333

8277

2.64

99.19

12.0

6.1

8.9

8.8

0.70

1280

7735

(3006504) Eosinophils/100 leukocytes in Blood

1329

8245

2.63

98.99

11.6

5.8

2.7

2.9

1.73

1269

7671

(3019198) Lymphocytes [#/volume] in Blood

1411

9011

2.68

98.97

11.1

5.6

e9/l

1.7

1.9

6.12

1245

7888

(3013115) Eosinophils [#/volume] in Blood

1424

9135

2.69

98.97

11.5

5.8

e9/l

0.2

1.00

1265

7966

(3022096) Basophils/100 leukocytes in Blood

1303

8029

2.61

98.08

11.7

5.8

0.7

0.97

1253

7484

(3024561) Albumin [Mass/volume] in Serum or Plasma

1277

7794

2.60

98.07

8.6

4.7

g/l

34.1

35.5

15.32

1218

7252

(3002030) Lymphocytes/100 leukocytes in Blood

1349

8471

2.62

97.27

11.8

5.9

25.5

27.9

12.27

1288

7882

(3018010) Neutrophils/100 leukocytes in Blood

1332

8340

2.60

96.19

11.2

5.7

59.3

57.2

8.41

1273

7790

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1393

8979

2.60

93.46

15.8

6.4

mmol/l

1.2

0.29

1225

7574

(3007853) Bacteria identified in Skin by Aerobe culture

497

1950

3.02

91.48

2.3

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

542

2306

2.81

85.29

10.3

5.5

mmol/l

1.1

1.0

1.00

515

2139

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1283

8193

2.43

84.06

13.2

5.7

mmol/l

1.2

0.42

1229

7385

(3032080) INR in Blood by Coagulation assay

1190

7366

2.40

83.48

9.5

9.3

inr

1.2

1.3

1.97

314

2095

(3018418) pH of Serum or Plasma

942

5305

2.39

81.50

9.9

3.8

7.4

0.91

196

999

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

359

1253

3.24

80.03

2.0

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

983

5674

2.36

79.95

3.9

2.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

531

2329

2.71

77.97

3.4

2.5

21.2

22.9

1.88

460

2001

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

169

349

5.17

77.83

2.1

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

263

767

3.77

77.46

1.8

g/l

1.7

1.6

2.07

241

666

(3020630) Protein [Mass/volume] in Serum or Plasma

385

1428

3.07

77.19

6.9

2.6

g/l

65.3

66.7

2.86

354

1318

(3004789) Transferrin [Mass/volume] in Serum or Plasma

551

2486

2.64

76.24

3.4

2.4

g/l

2.3

2.15

516

2313

(3027945) Reticulocytes/100 erythrocytes in Blood

470

1969

2.78

75.21

3.5

2.5

1.9

1.8

1.85

439

1750

(3022948) Iron [Moles/volume] in Serum or Plasma

578

2688

2.58

74.99

3.4

2.4

umol/l

11.7

13.2

5.48

546

2498

(3004588) Protein electrophoresis panel - Serum or Plasma

334

1166

3.21

74.10

6.6

2.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

609

2922

2.52

73.81

6.7

3.3

mmol/l

0.8

7.21

584

2741

(3037756) Immunofixation for Serum or Plasma

164

349

5.01

72.88

3.1

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1381

9451

2.32

72.16

13.0

6.2

umol/l

10.5

11.7

3.04

1341

8962

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

596

2863

2.50

71.77

2.6

1.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

788

4347

2.29

68.78

2.8

2.1

mg/l

2.9

3.0

0.62

709

3670

(3030467) Casts [#/volume] in Urine by Automated count

860

4933

2.25

68.16

4.4

3.0

e6/l

0.4

0.5

0.55

688

3701

(3005719) IgG [Mass/volume] in Serum or Plasma

342

1276

3.00

67.28

4.9

2.7

g/l

9.1

10.7

6.88

318

1163

(3002582) Erythrocytes [#/volume] in Urine

912

5390

2.21

66.78

4.6

3.2

e6/l

181.6

78.3

0.35

733

4124

(3021788) Differential panel - Synovial fluid

149

318

4.96

65.90

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

374

1485

2.84

65.55

3.1

2.7

e9/l

70.4

70.2

0.03

276

1146

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

782

4387

2.24

64.70

3.6

2.3

—

(3018095) Leukocytes [#/volume] in Urine

1007

6257

2.16

64.21

5.6

3.6

e6/l

65.6

120.0

2.08

765

4435

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1785

13991

2.72

64.20

17.3

7.4

u/l

84.7

78.1

4.57

1735

13153

(36304419) Bacteria [Presence] in Urine

833

4809

2.20

64.03

4.3

3.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

991

6171

2.14

62.25

6.8

3.4

mmol/l

2.3

2.4

1.44

903

5376

(3021589) Normoblasts [#/volume] in Blood

1181

7881

2.12

61.56

17.9

9.2

e9/l

0.0

0.80

986

6427

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

442

1994

2.54

59.62

2.4

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

441

1991

2.53

59.36

2.4

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

788

4596

2.14

57.63

6.7

3.8

91.4

90.1

0.75

779

4488

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

147

348

4.46

57.17

8.3

5.0

iu/ml

1303.6

834.0

0.31

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

205

619

3.56

56.81

7.0

2.1

g/l

8.9

10.4

3.79

166

538

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

213

670

3.42

55.37

7.2

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

213

670

3.42

55.37

7.2

2.1

g/l

7.7

7.4

1.08

155

519

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

213

670

3.42

55.37

7.2

2.1

g/l

3.6

3.8

0.48

150

494

(3000475) Leukocytes [#/volume] in Synovial fluid

163

432

4.00

54.55

1.6

1.7

e6/l

10734.1

13955.4

0.36

102

309

(3013707) Erythrocyte sedimentation rate by Westergren method

1688

13246

2.33

54.31

6.6

4.0

mm/h

17.7

12.4

26.03

1624

12224

(3013826) Glucose [Moles/volume] in Serum or Plasma

1440

10624

2.10

54.18

8.6

4.6

mmol/l

6.6

6.8

1.65

1404

9972

(3037467) Urinalysis macro (dipstick) panel - Urine

1592

12208

2.21

54.07

6.1

4.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

184

536

3.66

53.76

10.4

3.3

mg/l

66.6

62.6

0.08

154

438

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

181

522

3.70

53.67

10.1

3.3

ratio

38.9

2.8

0.56

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

184

538

3.65

53.46

10.4

3.3

mg/l

70.5

51.4

0.26

154

442

(3020779) Urea [Moles/volume] in Serum or Plasma

368

1596

2.58

53.44

11.5

7.3

mmol/l

10.9

9.7

2.18

353

1521

(3028026) IgM [Mass/volume] in Serum or Plasma

271

1008

2.94

52.98

2.7

1.8

g/l

1.0

1.4

3.65

250

919

(40760888) Immunoglobulin light chains.free panel - Serum

152

391

4.11

52.97

9.5

3.5

—

(3025577) Chromium [Mass/volume] in Blood

122

6.95

52.78

2.2

2.0

ug/l

2.4

2.2

0.18

106

(3000850) Epithelial cells [#/volume] in Urine

666

3745

2.13

52.65

3.4

2.5

e6/l

4.6

5.5

1.41

609

3262

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1083

7305

1.98

51.30

3.0

2.1

nmol/l

78.5

77.8

0.34

1012

6496

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

634

3.38

51.26

7.6

2.1

g/l

3.2

3.1

0.60

153

508

(3026470) Cobalt [Mass/volume] in Blood

124

6.75

50.76

2.2

2.0

ug/l

5.4

3.5

0.44

110

(3026782) Osmolality of Urine

623

3469

2.13

50.12

4.0

2.6

mosm/kgh2o

512.6

549.8

4.39

558

2938

(3021879) Hepatitis B virus core Ab [Presence] in Serum

280

1105

2.77

48.84

1.6

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

561

3037

2.15

48.29

3.5

2.7

e6/l

1.1

0.02

319

1716

(3031040) Bacteria [#/volume] in Urine by Automated count

1516

11645

2.05

47.77

6.1

4.4

e6/l

219.1

2260.8

2.56

172

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

151

418

3.81

47.44

2.1

1.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1050

7133

1.93

47.40

4.1

2.7

ug/l

178.4

138.1

5.10

993

6538

(3044941) Cell count panel - Synovial fluid

122

289

4.42

47.33

1.7

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

313

1338

2.57

46.43

5.3

3.6

ng/l

109.3

88.0

2.07

272

1161

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

182

579

3.34

46.28

7.6

2.2

g/l

1.5

1.0

0.65

160

514

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

122

295

4.33

46.08

2.2

1.7

—

(40758558) Short blood count panel - Blood

739

4491

1.99

46.04

16.3

6.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

146

406

3.79

45.55

2.2

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

159

473

3.55

44.88

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

523

2854

2.10

43.48

4.0

2.9

e6/l

3.0

2.3

0.79

284

1538

(21494890) Protein electrophoresis panel - 24 hour Urine

174

5.29

43.40

3.7

2.1

—

(3000991) Gas panel - Venous blood

329

1486

2.44

43.20

12.7

8.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

757

4729

1.93

42.83

4.4

2.6

umol/l

1238.2

5641.2

5.41

682

4102

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

220

4.67

41.57

8.0

7.0

mg/l

12.1

12.0

0.07

204

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

648

3882

1.96

41.20

2.4

1.8

mg/l

1.2

1.3

0.30

547

3001

(3017143) Hepatitis C virus Ab [Presence] in Serum

360

1728

2.30

41.02

2.0

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

7.78

40.87

32.9

25.9

ug/l

119.5

116.0

0.12

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

155

489

3.34

39.85

1.5

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

162

526

3.25

39.75

6.6

1.9

g/l

36.6

37.9

1.84

142

465

(3018677) aPTT in Platelet poor plasma by Coagulation assay

498

2750

2.06

39.65

3.1

2.1

30.1

29.7

0.76

488

2662

(3021960) Folate [Moles/volume] in Serum or Plasma

683

4210

1.92

39.59

1.8

1.5

nmol/l

20.6

20.8

0.16

624

3556

(3026008) Bacteria identified in Urine by Culture

818

5360

1.86

39.07

3.8

3.1

—

(3017181) Myelocytes/100 leukocytes in Blood

321

1497

2.35

38.98

5.5

4.1

0.9

0.8

0.20

131

435

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

118

319

3.86

38.28

1.7

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

157

514

3.22

37.98

6.9

2.0

g/l

0.0

0.64

142

479

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1053

7495

1.80

37.97

2.3

2.0

pmol/l

91.5

95.1

1.72

598

3791

(3052851) Hemolysis interference index of Serum or Plasma

160

530

3.18

37.96

4.1

3.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

299

1367

2.38

37.93

5.1

3.9

0.7

0.6

0.41

315

(3007164) IgA [Mass/volume] in Serum or Plasma

550

3200

1.97

37.52

2.5

1.4

g/l

2.4

2.5

0.45

359

1912

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

349

1717

2.24

37.23

2.2

g/l

0.2

0.64

330

1605

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2006

17823

3.24

37.16

33.6

13.9

mg/l

24.2

24.4

0.11

1831

14069

(3027801) Oxygen [Partial pressure] in Arterial blood

400

2086

2.13

36.81

9.9

7.6

kpa

11.6

12.5

3.67

379

1992

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

400

2086

2.13

36.81

9.9

7.6

kpa

5.1

0.06

382

1990

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

151

492

3.23

36.81

2.2

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

380

1952

2.15

36.32

1.9

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

184

4.71

35.89

2.3

1.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

116

326

3.71

35.57

1.7

1.3

—

14.1

—

(3003396) Base excess in Arterial blood by calculation

394

2081

2.10

34.91

10.0

7.6

mmol/l

1.2

1.1

0.18

329

1641

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

145

478

3.18

34.65

7.1

2.0

g/l

0.0

0.00

132

445

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

382

2003

2.11

34.47

5.0

2.6

umol/l

8.0

8.3

0.10

331

1768

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

104

279

3.87

34.09

1.4

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

793

5342

1.77

33.19

3.6

3.0

ng/l

1658.9

1284.2

0.84

698

4565

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

204

831

2.61

32.98

8.1

3.6

mmol/l

24.2

0.09

187

747

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

231

1000

2.47

32.87

1.6

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

183

707

2.74

32.86

2.2

2.0

ug/l

3.2

1.8

0.78

165

638

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

224

957

2.50

32.79

11.8

9.7

mmol/l

24.6

24.4

0.31

210

904

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

106

5.80

32.62

2.2

1.9

16.0

13.0

0.49

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

837

5748

1.75

32.61

5.4

3.2

u/l

36.4

38.3

0.20

792

5455

(3036481) Cortisol [Moles/volume] in Serum or Plasma

313

1555

2.19

32.30

2.7

2.1

nmol/l

357.0

378.0

1.01

293

1415

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

108

310

3.62

32.09

1.4

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

140

473

3.10

32.07

7.3

2.0

g/l

0.0

0.00

130

444

(3016502) Oxygen saturation in Arterial blood

355

1859

2.09

31.96

10.4

8.1

95.5

95.7

0.25

343

1793

(3021440) Promyelocytes/100 leukocytes in Blood

293

1431

2.22

31.51

5.7

4.2

0.1

0.25

118

403

(46235355) HIV 1 and 2 tests - Meaningful Use set

414

2307

1.99

31.34

2.0

1.7

—

(3011412) CD3 cells [#/volume] in Blood

141

4.95

31.01

2.7

2.0

e9/l

1.0

1.1

0.35

(3021447) Carbon dioxide [Partial pressure] in Venous blood

319

1624

2.13

30.85

6.8

3.4

kpa

6.0

5.8

0.96

309

1580

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

239

3.93

30.73

2.2

1.6

—

(3002032) Base excess in Venous blood by calculation

317

1615

2.13

30.58

6.8

3.5

mmol/l

2.1

1.9

0.29

267

1299

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

326

1684

2.11

30.32

2.6

2.3

u/l

31.9

41.2

1.49

271

1462

(3014111) Lactate [Moles/volume] in Serum or Plasma

311

1578

2.14

30.31

10.5

7.0

mmol/l

1.2

1.3

1.49

305

1525

(3019309) Folate [Moles/volume] in Red Blood Cells

540

3316

1.84

30.30

1.9

1.7

nmol/l

1230.0

1162.2

0.77

442

2478

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

551

3406

1.83

30.26

4.3

3.0

mmol/l

2.5

0.75

487

3007

(3042111) Morphology [Interpretation] in Bone marrow Narrative

103

298

3.58

30.24

2.4

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

408

2288

1.97

30.22

10.7

6.8

mmol/l

103.7

104.4

2.02

402

2238

(3025159) Blasts/100 leukocytes in Blood

276

1341

2.22

29.99

5.5

4.2

0.1

0.4

0.38

336

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

101

291

3.59

29.84

1.4

1.2

u/ml

225.0

254.2

0.45

171

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

236

1076

2.34

29.82

9.8

7.4

mmol/l

25.2

24.9

0.54

236

1070

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

101

5.67

29.80

2.4

1.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

101

292

3.58

29.69

1.7

1.4

u/ml

117.0

126.5

0.24

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

221

982

2.40

29.60

12.5

10.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

567

3570

1.80

29.13

4.4

3.7

ng/l

225.8

448.5

2.18

480

2814

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

798

5538

1.71

29.07

2.5

2.1

u/l

235.4

244.5

0.04

750

5179

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

116

373

3.23

28.85

1.6

1.4

—

(3000494) Fungus identified in Specimen by Culture

382

2127

1.97

28.76

1.8

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

111

350

3.29

28.51

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

111

350

3.29

28.51

1.6

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

127

434

3.05

28.51

1.4

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

327

1728

2.05

28.50

11.3

8.5

g/l

114.5

121.8

9.29

319

1662

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

129

450

2.99

27.93

5.8

2.8

mg/l

1.7

1.5

1.10

121

410

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

104

5.40

27.83

2.5

2.1

e6/l

559.9

764.1

0.81

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

230

1070

2.29

27.67

2.0

1.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

797

5593

1.68

27.45

3.3

2.6

u/l

54.3

57.9

1.75

745

5152

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

213

3.91

27.31

1.5

61.4

62.0

0.04

134

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

129

458

2.93

27.06

1.5

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

401

2325

1.89

26.57

1.5

1.3

titre

672.4

482.4

0.99

496

(3021601) Nitrite [Presence] in Urine by Test strip

1122

8659

1.63

26.06

6.3

4.9

estimate

0.0

0.50

258

1602

(3017704) Immunofixation for Urine

103

5.25

26.03

2.9

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

1132

8759

1.63

25.99

4.8

3.6

estimate

0.0

0.21

248

1547

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

159

4.32

25.92

2.7

2.4

—

(3002385) Erythrocyte distribution width [Ratio]

1707

14702

1.82

25.92

39.1

17.2

14.3

13.7

38.24

1689

14362

(3047189) Immunofixation for 24 hour Urine

5.86

25.43

3.0

1.6

—

(3044889) 12 lead EKG panel

1546

12982

1.70

25.27

4.7

3.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

299

3.32

25.15

1.9

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

173

4.09

24.84

1.3

1.2

u/l

73.4

55.3

0.66

126

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

340

1906

1.93

24.82

4.5

3.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

5.37

24.70

2.0

2.8

36.0

38.1

0.21

(3023183) Ammonium ion [Moles/volume] in Plasma

111

382

3.01

24.61

2.2

2.9

umol/l

33.2

38.4

0.90

330

(3035350) Ketones [Presence] in Urine by Test strip

1110

8627

1.60

24.39

4.8

3.6

estimate

0.0

0.00

242

1582

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

147

595

2.58

23.96

3.1

3.0

u/ml

0.4

0.06

339

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

117

421

2.88

23.95

1.6

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

154

4.19

23.47

1.4

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2023

18668

2.74

23.25

34.6

16.3

mmol/l

139.0

139.7

23.86

2002

18188

(44790048)

203

3.69

22.75

1.8

1.5

—

(44790047)

203

3.69

22.75

1.8

1.5

—

(44806118)

203

3.69

22.75

1.8

1.5

—

(44790049)

203

3.69

22.75

1.8

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

128

4.47

22.74

1.6

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

145

598

2.53

22.73

2.5

2.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2023

18718

2.68

22.18

35.6

16.4

mmol/l

4.0

0.84

2000

18213

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

299

3.13

21.85

4.4

3.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

147

622

2.46

21.82

2.2

ug/l

457.2

497.4

0.08

141

585

(3020876) Protein [Mass/time] in 24 hour Urine

147

4.10

21.44

2.5

2.1

—

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

599

4115

1.63

21.25

4.5

3.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

284

3.15

21.13

4.2

3.4

1.4

1.5

0.07

231

(21494814) CD8 cells/100 lymphocytes in Specimen

6.19

21.13

1.5

1.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

130

533

2.53

20.63

4.0

2.0

95.8

91.5

1.22

125

502

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

229

3.36

20.31

1.9

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

242

3.26

19.91

2.0

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

151

3.92

19.87

1.4

26.0

30.7

0.42

(3003181) Sodium [Moles/volume] in Urine

299

2.99

19.36

1.4

1.3

mmol/l

60.5

59.6

0.06

239

(3042733) HLA Ab [Presence] in Serum

6.54

19.21

5.1

5.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

246

1348

1.93

18.96

5.5

2.8

kpa

4.9

4.5

1.15

237

1306

(3001964) Herpes simplex virus Ag [Presence] in Specimen

6.60

18.76

2.1

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

222

1182

1.98

18.60

12.6

9.1

94.0

0.02

222

1175

(3036489) Thrombin time

145

658

2.29

18.38

3.7

1.9

21.8

21.5

0.22

135

586

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

4.50

17.78

3.1

2.0

e6/l

574.1

616.0

0.12

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

330

2021

1.75

17.70

1.9

1.7

1.5

2.23

266

1771

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

271

1566

1.84

17.67

3.5

2.8

ng/l

172.4

186.7

0.30

243

1419

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

217

1169

1.95

17.55

12.8

9.1

0.6

0.7

2.34

217

1162

(3023420) DNA double strand Ab [Units/volume] in Serum

180

3.46

17.45

2.5

1.3

iu/ml

47.2

34.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

257

1468

1.85

17.38

9.3

3.5

mmol/l

1.2

0.11

244

1269

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.38

17.32

2.6

2.3

—

(40768804) Tissue Pathology biopsy report

930

7300

1.49

17.24

2.4

2.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

108

4.24

17.22

2.0

1.6

u/l

6.4

7.1

0.10

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

6.24

17.21

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

192

3.35

17.14

1.7

1.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

217

1179

1.94

17.10

12.6

8.9

1.3

0.39

217

1172

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1869

17055

1.80

17.04

28.0

13.2

ml/min/173m2

80.0

79.4

0.53

1646

14086

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

178

3.44

17.03

1.8

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

269

2.93

16.67

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

211

1146

1.93

16.64

5.1

3.5

kpa

5.1

5.2

0.14

200

1064

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

264

2.95

16.62

2.0

1.4

—

(3009343) pH of Capillary blood

208

1129

1.93

16.43

5.1

3.5

7.4

0.11

139

(3034891) Synovial lining cells/100 cells in Synovial fluid

4.80

16.14

1.3

4.8

3.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

9.58

16.12

11.5

12.8

mmol/l

7.5

5.8

0.35

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

9.58

16.12

1.6

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

297

2.80

16.06

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.77

15.90

5.8

4.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

133

3.75

15.88

2.4

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

200

1084

1.93

15.86

5.1

3.5

mmol/l

1.6

1.8

0.29

153

812

(3003694) ABO and Rh group [Type] in Blood

647

4783

1.51

15.75

1.5

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

5.06

15.74

1.9

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

5.06

15.74

1.9

1.8

—

(40758292) HTLV I+II Ab panel - Serum

7.66

15.70

1.6

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

9.12

15.55

1.9

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.99

15.48

1.9

1.8

—

(3025941) Bacteria identified in Stool by Culture

173

901

2.00

15.39

1.3

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

527

3753

1.54

15.20

7.3

4.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

336

2.63

15.10

5.1

3.3

57.5

57.2

0.06

336

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

115

3.89

15.05

1.2

—

(3045142) Bone marrow Pathology biopsy report

209

3.08

14.95

1.5

1.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

322

2.64

14.78

4.5

3.1

e9/l

4.2

0.00

322

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

439

3020

1.57

14.72

1.4

1.3

iu/ml

36.7

37.1

0.02

131

971

(3008536) Aspergillus sp Ab [Presence] in Serum

6.16

14.67

3.4

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

4.16

14.66

3.3

2.0

e9/l

0.2

0.11

(40761511) CBC panel - Blood by Automated count

1978

18515

1.99

14.64

26.9

13.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

4.31

14.56

1.8

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

4.31

14.56

1.8

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

4.31

14.56

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

4.31

14.56

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

4.31

14.56

1.8

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

4.31

14.56

1.8

1.7

—

(3024928) Oxygen saturation in Venous blood

394

2.45

14.27

5.5

2.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1348

11610

1.44

14.07

4.4

3.1

u/l

77.1

50.7

7.56

1271

10757

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.97

14.06

1.3

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

130

637

2.11

13.64

1.3

1.2

u/ml

0.3

0.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

501

3601

1.51

13.63

1.3

1.2

u/ml

0.9

1.6

2.28

113

914

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

419

2903

1.55

13.50

1.3

1.2

u/ml

13.9

11.1

0.29

146

1095

(3019060) Gas panel - Arterial blood

206

1186

1.82

13.50

6.0

5.2

—

(4035726)

269

1673

1.70

13.46

1.5

1.4

—

(3024471) HLA-A [Type]

5.25

13.44

1.0

—

(3024932) HLA-DR beta [Type]

5.25

13.44

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

7.36

13.13

2.0

1.1

—

(3037121) Protein [Mass/volume] in Urine

123

601

2.11

13.01

3.7

3.3

g/l

0.6

0.3

0.58

240

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

4.20

12.97

3.9

2.5

u/ml

826.6

1354.3

0.80

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2021

19160

2.12

12.89

21.6

10.5

u/l

27.0

26.7

0.11

1983

18462

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.86

12.63

2.5

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.17

12.51

1.4

1.2

—

(1616796) Gas panel - Central venous blood

382

2.36

12.40

5.7

3.8

—

(21494434) Karyotype in Bone marrow

168

3.09

12.30

1.2

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

223

2.79

12.23

2.2

2.1

—

4.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

153

3.19

12.23

1.7

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

153

3.19

12.23

1.7

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

153

3.19

12.23

1.7

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.80

12.01

2.6

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

140

740

1.95

11.94

2.5

1.9

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

171

3.03

11.94

3.8

2.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1199

10272

1.38

11.86

2.9

2.7

—

(3048689) Calprotectin [Mass/mass] in Stool

300

1979

1.60

11.84

2.3

2.2

ug/g

145.6

137.3

0.16

248

1573

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

119

599

2.05

11.65

1.8

1.5

titre

115.6

403.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.55

11.65

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

103

3.64

11.62

1.3

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

8.39

11.49

3.8

2.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

1749

16055

1.51

11.41

35.5

15.2

37.7

39.8

16.75

1254

11286

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

160

3.05

11.37

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

161

3.03

11.25

1.1

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

245

2.62

11.23

1.4

1.2

u/ml

6.0

3.0

0.60

(3017446) Testosterone [Moles/volume] in Serum or Plasma

213

1305

1.70

11.22

2.5

2.3

nmol/l

9.9

13.2

5.76

174

1157

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.85

11.02

1.4

1.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

343

2373

1.53

10.94

26.6

24.5

inr

1.3

0.02

346

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

133

713

1.92

10.90

6.0

3.8

mmol/l

24.8

24.9

0.20

125

666

(3000093) Morphology [Interpretation] in Blood Narrative

143

3.12

10.88

1.0

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

379

2.27

10.86

3.7

2.4

15.4

16.3

1.00

183

(3000060) B lymphocytes [#/volume] in Blood

5.98

10.86

3.9

1.7

e6/l

75.4

206.4

1.16

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

244

2.59

10.81

1.5

1.2

u/ml

3.3

5.8

0.94

101

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.16

10.79

1.1

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

381

2.25

10.73

1.5

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

275

2.48

10.71

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

105

523

2.06

10.59

2.3

1.7

—

(3007461) Platelets [#/volume] in Blood

2060

19801

2.32

10.59

46.2

20.7

e9/l

256.4

249.0

4.73

2021

19270

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

308

2.38

10.53

1.2

u/l

54.9

41.8

0.38

266

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

133

722

1.90

10.50

7.4

6.0

1.8

1.6

1.08

127

672

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

127

679

1.93

10.49

2.1

1.8

—

(3024731) MCV [Entitic volume]

2060

19806

2.31

10.49

46.0

20.7

92.4

91.2

24.05

2046

19502

(3035941) MCH [Entitic mass]

2060

19807

2.31

10.47

45.9

20.6

30.5

30.4

3.93

2046

19502

(3017354) Segmented neutrophils/100 leukocytes in Blood

179

2.84

10.46

4.4

3.3

62.5

54.9

1.31

123

(3026361) Erythrocytes [#/volume] in Blood

2060

19809

2.31

10.44

46.1

20.7

e12/l

4.2

4.5

82.18

2016

19223

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

111

3.37

10.42

2.5

1.5

—

(3010813) Leukocytes [#/volume] in Blood

2060

19812

2.30

10.38

46.1

20.8

e9/l

6.9

6.7

5.49

2018

19228

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

191

2.77

10.38

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

2060

19813

2.30

10.36

46.4

20.9

g/l

127.9

135.8

85.81

2043

19506

(3007566) Smooth muscle Ab [Titer] in Serum

467

2.11

10.32

1.2

titre

93.3

83.4

—

(3036603) Volume of Urine

117

3.29

10.28

2.0

1.4

2148.0

2004.0

—

(3027315) Oxygen [Partial pressure] in Blood

408

2.18

10.26

6.4

4.7

kpa

8.5

0.00

403

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.51

10.18

1.9

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

424

2.15

10.10

1.4

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1512

13616

1.38

10.06

4.3

4.0

pmol/l

14.7

14.9

1.17

1392

12322

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

228

1463

1.63

10.04

2.6

ml/min/173m2

64.3

65.4

0.15

102

581

(3016038) Potassium [Moles/volume] in Urine

104

3.40

10.01

1.3

1.1

mmol/l

31.1

34.2

0.36

(4268621)

167

2.86

9.98

2.5

2.3

—

(3023419) Bacteria identified in Sputum by Culture

230

2.56

9.98

2.7

2.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

168

2.84

9.88

1.1

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

208

2.64

9.85

1.3

1.4

e6/l

3980.4

1758.3

0.76

151

(3012501) Base excess in Blood by calculation

405

2.14

9.65

6.5

4.6

mmol/l

2.5

2.7

0.22

282

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

3.44

9.60

2.5

1.8

—

(3013290) Carbon dioxide [Partial pressure] in Blood

406

2.14

9.60

6.5

4.6

kpa

5.0

5.1

0.60

401

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.95

9.59

3.1

4.1

—

(3048879) Bone marrow aspiration report

4.46

9.55

2.2

2.0

—

(40768446) Kidney Pathology biopsy report

4.04

9.51

2.2

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

177

1082

1.69

9.40

5.1

3.0

g/l

121.7

129.4

3.83

171

1055

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

505

2.01

9.39

1.8

1.6

iu/ml

4.6

12.9

0.27

(1761868) Lipid panel - Serum or Plasma

490

6275

0.72

9.38

3.0

2.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

124

3.10

9.37

1.3

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

196

2.64

9.36

1.8

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

192

2.64

9.20

5.9

3.0

—

(3022313) Gas panel - Capillary blood

144

836

1.78

9.18

5.4

3.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

181

2.69

9.15

1.3

1.4

e6/l

93591.3

96718.7

0.02

105

(36660697) Celiac disease serology panel - Serum

203

1295

1.63

9.14

1.2

—

(3025315) Body weight

9.21

8.98

4.7

4.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

127

715

1.83

8.97

7.7

6.0

0.9

0.10

121

667

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

141

820

1.77

8.94

4.4

2.4

0.6

0.7

0.79

134

782

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.33

8.90

1.9

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

832

6932

1.33

8.90

4.8

3.5

ng/l

51.8

51.6

0.01

630

4876

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

7.26

8.85

3.5

2.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

153

917

1.72

8.74

1.6

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.68

8.72

1.9

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.68

8.72

1.9

1.4

—

(3042631) Mycobacterium sp identified in Specimen

240

2.41

8.68

2.4

2.6

—

(40762814) Titanium [Mass/volume] in Blood

5.35

8.68

2.5

2.1

ug/l

2.7

3.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.27

8.63

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.33

8.62

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.33

8.62

1.1

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.03

8.62

1.6

1.4

—

(3044927) Protein electrophoresis panel - Urine

176

2.65

8.54

1.3

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1757

16376

1.42

8.42

5.2

4.7

mu/l

1.9

2.1

0.94

1647

14907

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

133

775

1.76

8.39

2.0

1.8

u/l

39.9

39.2

0.14

117

681

(3008295) Osmolality of Serum or Plasma

172

2.65

8.38

1.2

1.3

mosm/kgh2o

276.4

279.0

0.32

131

(3009508) Creatinine [Moles/volume] in Urine

714

5866

1.33

8.27

3.9

3.2

mmol/l

6.8

7.5

3.82

620

4915

(3006184) Hemoglobin [Mass/volume] in Capillary blood

376

2.09

8.25

2.9

2.2

g/l

123.7

130.1

1.12

275

(3024980) IgG subclass 4 [Mass/volume] in Serum

259

2.31

8.21

1.3

1.7

g/l

0.5

0.8

1.67

201

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

14.52

8.20

1.6

1.2

—

(3028433) Virus identified in Specimen by Culture

4.03

8.07

1.2

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1797

16851

1.43

8.01

6.5

5.9

mmol/mol

40.0

40.1

0.10

1699

15536

(3010144) Erythrocytes [#/volume] in Synovial fluid

165

2.64

7.96

1.3

1.4

e6/l

111106.3

79738.6

0.12

110

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

3.29

7.94

5.2

5.9

u/ml

54.0

69.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

5.19

7.93

3.3

2.9

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

201

2.47

7.92

1.3

1.2

u/ml

69.9

62.0

—

(40768797) Stomach Pathology biopsy report

348

2568

1.42

7.86

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

176

1127

1.61

7.81

9.0

7.3

mmol/l

24.7

24.6

0.14

167

1047

(3008757) Leukocyte morphology finding [Identifier] in Blood

197

2.47

7.76

5.5

4.1

—

(3022145) Colonoscopy Study observation

286

2039

1.47

7.76

1.4

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

492

3855

1.36

7.75

1.7

pmol/l

468.2

27150035.3

3.04

416

3175

(3044290) Cell count panel - Cerebral spinal fluid

353

2.08

7.66

2.0

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

223

2.37

7.65

1.7

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

223

2.37

7.65

1.7

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

223

2.37

7.65

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

224

2.35

7.58

1.7

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

226

2.33

7.43

1.7

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

153

959

1.64

7.41

2.5

2.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

227

2.32

7.36

1.4

1.5

g/l

34.1

32.5

0.42

208

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

227

2.32

7.36

1.7

1.5

—

(3012516) Albumin [Mass/volume] in Urine

682

5644

1.31

7.30

4.4

3.2

mg/l

1681.9

293.7

3.98

480

3527

(3045788) Cell count panel - Pleural fluid

161

2.58

7.28

1.3

1.4

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

5.41

7.25

3.8

3.1

—

(3002256) Pathology report gross observation

319

2352

1.42

7.21

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

223

2.32

7.20

1.7

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

168

2.53

7.18

4.1

3.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

7.72

7.12

1.0

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

140

2.67

7.07

1.2

1.1

titre

98.8

131.4

—

(3012441) Differential panel - Pleural fluid

176

2.47

7.02

1.3

1.4

—

(4010399)

192

1287

1.54

7.01

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.87

6.98

1.4

1.1

g/l

42.1

38.0

0.78

(3012565) Volume of 24 hour Urine

3.24

6.97

2.9

2.6

1988.1

1977.6

0.02

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

147

2.61

6.96

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

573

4669

1.31

6.78

5.8

3.9

estimate

0.0

1.08

238

1552

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

110

2.85

6.69

1.2

1.4

—

256.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

157

2.51

6.61

1.5

1.4

g/l

0.4

0.09

107

(3027135) IgG subclass 1 [Mass/volume] in Serum

157

2.51

6.61

1.5

1.4

g/l

7.9

6.8

0.27

107

(3028192) IgG subclass 2 [Mass/volume] in Serum

157

2.51

6.61

1.5

1.4

g/l

2.3

2.9

0.76

107

(3000570) Elastase.pancreatic [Mass/mass] in Stool

540

1.79

6.58

1.5

1.4

ug/g

269.9

276.1

0.11

309

(3003327) Ova and parasites identified in Stool by Light microscopy

496

1.83

6.57

1.7

1.6

—

(3047181) Lactate [Moles/volume] in Blood

564

1.77

6.51

9.2

7.1

mmol/l

1.2

1.3

0.26

489

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

240

2.20

6.50

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

4.85

6.45

1.4

1.5

—

(4062490)

159

2.48

6.44

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

3.60

6.31

1.4

1.3

26.2

24.1

0.10

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

445

1.85

6.27

1.4

1.2

u/ml

26.6

2.6

—

(3039000) Anion gap in Blood

395

1.90

6.26

10.4

8.5

mmol/l

11.3

11.1

0.15

349

(3018572) Chloride [Moles/volume] in Blood

395

1.90

6.26

10.4

8.5

mmol/l

103.2

105.5

2.28

349

(3015235) Bicarbonate [Moles/volume] in Capillary blood

461

1.83

6.21

3.2

3.0

mmol/l

25.0

25.1

0.04

401

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

127

2.62

6.14

1.2

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

128

2.60

6.05

1.4

u/ml

34.6

22.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

100

2.82

6.00

2.5

1.7

u/field

0.6

3.9

1.19

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

454

1.82

5.90

1.4

1.2

u/ml

2.7

10.9

1.50

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.30

5.86

1.7

2.4

umol/l

106.0

174.3

—

(3035933) Granulocytes/100 leukocytes in Blood

3.80

5.81

1.9

2.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

11.16

5.79

1.2

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

699

5940

1.26

5.78

4.6

4.0

mg/mmol

18.4

8.4

3.39

471

3709

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.62

5.76

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

3.92

5.71

1.7

1.3

—

(3021901) Oxygen saturation in Capillary blood

329

1.94

5.71

3.3

2.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

388

1.86

5.62

2.0

1.5

e6/l

794.1

1057.6

0.18

315

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

388

1.86

5.62

2.0

1.4

e6/l

20.6

36.2

0.31

300

(3000012) Reticulocyte production index

2.79

5.47

1.5

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.97

5.44

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.56

5.32

2.1

1.2

—

(3034426) Prothrombin time (PT)

3.42

5.31

1.2

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

338

1.89

5.30

1.3

1.2

u/ml

32.7

46.6

—

(3023410) Appearance of Cerebral spinal fluid

182

2.22

5.23

2.3

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

290

1.96

5.23

1.5

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1472

0.61

5.22

1.8

—

(21494755) Public health laboratory ask at order entry panel

1396

0.60

5.17

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

363

1.84

5.15

1.7

1.3

u/l

8.6

9.7

0.32

298

(4306422)

244

2.03

5.11

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

764

6631

1.24

5.09

5.2

3.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

2.86

5.09

1.1

u/l

91.9

83.0

0.22

(3051651) Icteric interference index of Serum or Plasma

116

2.52

5.04

7.3

3.1

—

(3016018) Differential panel - Cerebral spinal fluid

185

2.18

5.04

1.9

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

2.82

4.98

1.1

u/l

32.7

21.4

0.39

(3009871) Measles virus Ab [Titer] in Serum

3.35

4.88

1.9

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

175

2.19

4.85

3.7

2.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.72

4.84

1.5

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

257

1951

1.36

4.84

5.0

4.2

ug/l

25.2

15.7

0.41

207

1591

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

5.02

4.78

6.9

5.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

150

1038

1.48

4.77

2.7

3.3

pmol/l

4.4

4.5

0.49

136

911

(3014765) Yersinia sp identified in Stool by Organism specific culture

510

1.67

4.70

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

504

1.67

4.64

1.3

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

547

4619

1.25

4.60

4.5

3.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

14.04

4.57

1.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

116

2.43

4.55

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

116

2.43

4.55

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

116

2.43

4.55

1.3

1.1

—

(40768443) Skin Pathology biopsy report

120

801

1.53

4.54

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

515

1.66

4.54

1.3

1.1

—

(40768806) Pleura Pathology biopsy report

182

2.11

4.43

1.4

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

119

2.37

4.33

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

119

2.37

4.33

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

119

2.37

4.33

1.3

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

963

0.57

4.25

1.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

2.64

4.23

1.4

1.9

114.2

97.3

1.25

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

249

1.91

4.17

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.00

4.12

1.2

—

(3000492) Spirometry study

220

1677

1.35

4.05

1.6

1.5

—

(3024263) Appearance of Synovial fluid

2.47

4.05

1.4

1.9

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

10.03

4.01

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

176

2.06

4.01

1.3

1.6

—

(40761535) Cells panel - Urine sediment

200

1505

1.36

4.01

4.9

3.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

314

2524

1.29

3.96

1.5

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.14

3.93

3.1

2.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

151

2.14

3.90

1.3

u/l

526.4

339.9

0.80

145

(3019225) pH of Specimen

239

1856

1.32

3.89

10.2

4.1

—

(3035880) pH of Pleural fluid

2.46

3.88

1.2

1.4

—

(3017569) Oxygen content in Arterial blood

2.52

3.88

2.0

2.7

—

(3025130) Human papilloma virus identified in Specimen

165

2.08

3.87

1.7

1.9

—

(3020393) Adenovirus Ag [Presence] in Stool

7.30

3.86

1.6

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.08

3.80

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.49

3.80

3.8

3.4

—

(3032057) Clostridioides difficile [Presence] in Stool

3.54

3.76

2.1

1.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

12.03

3.76

1.2

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

2.74

3.75

2.5

1.7

nmol/l

8.3

2.4

0.53

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

202

1.95

3.73

1.8

—

1370.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

144

1039

1.41

3.72

1.4

1.3

u/ml

277.0

223.8

0.30

131

959

(4198724)

3.13

3.65

1.5

1.6

—

(40761536) Microorganisms panel - Urine sediment

195

1484

1.35

3.65

6.0

3.9

—

(40757373) Influenza virus identified in Isolate

3.26

3.62

1.6

—

(4212803)

7.80

3.56

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

165

2.02

3.50

1.2

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

310

1.73

3.48

1.6

1.4

—

(3049717) Cytology report of Urine Cyto stain

106

732

1.47

3.48

2.2

2.6

—

(3017732) Neutrophils [#/volume] in Blood

159

1187

1.37

3.38

3.6

3.1

e9/l

4.2

4.0

0.29

121

923

(40763480) Human metapneumovirus Ag [Presence] in Specimen

8.59

3.26

1.2

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

207

1618

1.31

3.24

2.4

2.3

ug/l

8.6

7.0

0.27

173

1448

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

257

1.77

3.23

1.6

1.5

—

(3011648) Oxygen content in Venous blood

151

2.00

3.15

6.1

1.7

10.1

11.4

1.09

151

(3009466) Valproate [Moles/volume] in Serum or Plasma

260

1.75

3.11

5.0

5.2

umol/l

333.6

366.9

0.79

230

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

7.52

3.05

1.3

1.6

—

(3042517) Benzodiazepines panel - Urine

5.85

3.02

2.0

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.15

2.93

1.5

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.72

2.92

1.4

umol/l

58.1

56.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

122

2.06

2.87

1.7

1.9

nmol/l

19.8

18.3

0.24

112

(3021387) Prolactin [Units/volume] in Serum or Plasma

415

1.56

2.87

1.9

1.5

mu/l

308.2

291.6

0.24

380

(3020191) Ethanol [Moles/volume] in Serum or Plasma

129

2.03

2.86

1.2

1.5

promille

1.3

1.2

0.10

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

144

1.96

2.80

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

107

777

1.40

2.74

5.5

3.6

45.7

48.8

0.58

107

767

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.15

2.71

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.14

2.64

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

672

6051

1.16

2.61

7.4

4.8

ug/l

7.6

2.5

3.72

613

5442

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.90

2.58

1.0

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

4.01

2.56

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

101

2.09

2.53

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.04

2.52

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

3.34

2.39

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

410

1.50

2.38

1.6

1.8

iu/l

6.1

5.1

0.17

132

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.65

2.36

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.65

2.36

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.65

2.36

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

155

1.82

2.30

2.5

2.2

u/field

1.2

1.8

0.46

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

398

1.50

2.27

1.3

miu/ml

257.6

213.1

0.30

178

(3004716) Salmonella sp identified in Stool by Organism specific culture

107

804

1.35

2.27

1.4

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.63

2.27

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

5.56

2.21

1.4

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

210

1.68

2.20

1.3

1.4

pmol/l

349.8

312.0

0.18

164

(3008898) HLA-B27 [Presence]

551

1.41

2.20

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.79

2.20

1.1

—

(3020891) Body temperature

731

1.36

2.19

5.7

4.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

635

0.64

2.17

2.1

1.7

mg/l

5.9

3.9

0.58

450

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

101

1.99

2.15

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

101

1.99

2.15

1.0

1.1

u/l

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

183

1.70

2.08

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

3.51

2.05

1.4

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.33

2.05

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.51

2.01

1.3

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

104

1.93

2.00

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

4.55

1.94

1.0

2.8

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.55

1.94

1.6

5.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.55

1.94

1.0

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

3.54

1.84

1.7

2.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1808

17634

1.17

1.83

5.0

4.7

mmol/l

6.1

6.0

1.77

1670

16009

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

2.27

1.80

1.5

2.5

239.3

171.9

0.80

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

133

1067

1.26

1.80

1.7

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

147

1194

1.25

1.79

1.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

489

1.38

1.76

1.3

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

124

1.78

1.76

2.4

1.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

282

1.50

1.72

1.2

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.85

1.71

1.0

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.88

1.70

1.4

1.8

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.07

1.70

2.6

2.2

—

(3014271) Vancomycin [Susceptibility]

1.96

1.69

3.2

3.0

—

(3045414) Leukocytes [Presence] in Urine

103

813

1.28

1.62

2.8

1.9

—

(3019150) Specific gravity of Urine by Refractometry

421

3786

1.14

1.62

5.4

4.0

kg/l

1.0

0.31

555

(3016330) Potassium [Moles/time] in 24 hour Urine

3.58

1.61

1.0

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.58

1.61

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.58

1.61

1.2

1.1

—

(3019977) pH of Arterial blood

1.88

1.60

2.6

3.0

7.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

238

1.52

1.60

1.5

1.3

nmol/l

0.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.70

1.58

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.21

1.57

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.21

1.57

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.21

1.57

1.3

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.21

1.57

1.3

1.4

102.3

88.3

—

(3013637) Mi-2 Ab [Presence] in Serum

2.21

1.57

1.3

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.43

1.53

2.4

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

770

0.73

1.53

1.4

1.7

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

3.34

1.52

1.4

2.1

mg/l

1.2

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.34

1.52

1.2

—

(3005570) Glucose [Moles/volume] in Urine

177

1.59

1.52

2.3

2.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

209

1.54

1.51

1.5

1.3

nmol/l

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.16

1.50

1.4

1.1

92.8

89.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.16

1.50

1.5

1.1

106.3

104.8

0.05

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

1.49

0.0

2.4

—

8.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.91

1.49

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.01

1.48

1.2

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.13

1.44

1.0

—

(3011288) Drugs identified in Urine by Screen method

262

1.46

1.41

6.2

2.9

—

(3016879) Cocaine [Presence] in Urine

363

1.39

1.41

3.8

2.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

103

1.75

1.41

1.2

—

(3013512) EKG study

589

5449

1.11

1.40

4.9

3.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

126

1.67

1.40

1.6

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.78

1.39

1.6

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.08

1.38

2.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

215

1.50

1.36

2.1

2.3

mg/l

18.1

27.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

120

1.67

1.34

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.13

1.33

1.1

1.0

—

(40768795) Lymph node Pathology biopsy report

184

1.53

1.32

1.3

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

300

1.41

1.31

3.5

2.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.74

1.31

1.8

2.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

438

1.33

1.30

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

169

1.55

1.29

1.5

nmol/l

0.3

0.03

125

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.89

1.28

2.3

2.1

ug/l

22.9

133.8

0.45

(3039443) Prostate specific Ag panel - Serum or Plasma

388

0.67

1.26

1.6

1.7

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.40

1.24

1.2

101.8

100.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.40

1.24

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.77

1.23

1.1

ratio

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

288

1.40

1.21

1.1

iu/ml

62.2

79.0

—

(3014891) Appearance of Pleural fluid

2.31

1.18

1.5

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

419

1.32

1.18

3.6

2.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

129

0.46

1.16

1.5

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

447

1.31

1.16

1.1

u/ml

2.4

4.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.06

1.15

2.1

2.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

430

1.31

1.15

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

110

916

1.21

1.15

4.4

3.8

u/ml

76.4

64.5

0.14

105

882

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.34

1.12

1.0

1.1

—

6.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

728

1.23

1.11

1.1

titre

588.0

147.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.79

1.11

1.4

1.1

iu/ml

190.3

221.4

0.11

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.26

1.10

1.0

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

168

1.49

1.09

1.2

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

164

0.55

1.08

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

227

1.42

1.08

1.2

—

(3004451) EKG impression Narrative

1.69

1.07

1.5

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

506

1.27

1.07

1.8

1.3

iu/l

25.3

32.2

0.91

433

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

219

1.42

1.07

1.6

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

500

0.74

1.07

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

388

3565

1.11

1.06

3.2

3.0

ug/l

1.0

0.7

1.30

279

2343

(3032773) Endomysium IgG Ab [Titer] in Serum

129

1.56

1.05

1.1

—

(40768441) Liver Pathology biopsy report

129

1.56

1.05

1.4

1.3

—

(3028300) Cannabinoids [Presence] in Urine

393

1.31

1.04

3.8

2.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.06

1.03

10.3

8.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

122

1.56

1.02

1.1

mg/l

35.7

44.2

0.71

106

(4211845)

1.69

1.01

7.4

3.4

—

(3027944) Amphetamines [Presence] in Urine

387

1.30

1.00

3.6

2.0

—

(4015189)

1.84

0.98

1.6

2.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

157

0.57

0.98

1.2

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.67

0.97

1.4

u/l

213.3

476.9

1.10

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

232

1.39

0.97

1.1

—

(4027681)

1.63

0.97

1.4

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

165

1.46

0.96

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.80

0.96

8.3

7.3

—

(3000764) Benzodiazepines [Presence] in Urine

390

1.29

0.95

3.8

2.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

173

0.58

0.95

1.3

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.65

0.94

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.89

0.94

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.23

0.93

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

145

0.55

0.93

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

145

0.55

0.93

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

146

0.55

0.92

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

146

0.55

0.92

1.3

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

518

4860

1.09

0.91

5.0

4.2

21.3

21.1

0.09

244

2348

(3051387) C reactive protein [Mass/volume] in Capillary blood

395

0.73

0.91

5.1

3.6

mg/l

26.0

25.7

0.02

253

(3027008) Opiates [Presence] in Urine

393

1.28

0.91

3.8

2.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

110

1.55

0.90

1.9

1.7

umol/l

14.5

6.7

0.57

(3006653) Thiamine [Moles/volume] in Blood

102

1.57

0.90

1.3

nmol/l

154.4

145.1

0.18

102

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

210

2332

0.89

0.88

4.7

4.6

32.3

32.6

0.14

154

1554

(3004775) Volume in Urine collected for unspecified duration

152

1.45

0.88

3.5

2.2

900.5

625.2

1.16

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.86

0.87

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.82

0.86

2.3

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

642

1.21

0.85

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

266

2429

1.11

0.84

1.5

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

1.74

0.82

1.3

mu/l

155.0

64.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.74

0.82

1.1

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

376

1.26

0.77

2.1

1.5

nmol/l

0.8

0.14

307

(3023511) Choriogonadotropin [Units/volume] in Urine

140

1.43

0.77

1.7

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

115

1.48

0.76

1.1

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

174

1.38

0.76

2.5

1.6

—

(3022621) pH of Urine by Test strip

131

1155

1.14

0.76

3.7

3.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.70

0.75

2.1

2.3

ug/l

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.70

0.75

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.67

0.74

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

117

1.46

0.71

2.2

2.4

—

(3006462) Nitrate [Presence] in Urine

1.58

0.71

8.4

3.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

444

1.22

0.71

3.3

2.3

ug/min

127.0

114.0

0.10

264

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

275

0.72

0.70

1.2

1.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.93

0.70

3.2

5.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.93

0.70

1.6

2.8

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

247

1.30

0.70

2.4

2.3

u/ml

690.7

69.9

0.43

239

(40762365) Oxygen content in Arterial blood by calculation

1.71

0.70

1.7

2.8

ml/dl

15.1

15.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.53

0.68

1.1

1.2

—

(4133840)

1.63

0.67

1.4

1.2

—

(3000285) Sodium [Moles/volume] in Blood

1.79

0.66

1.2

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

232

1.30

0.66

1.0

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.73

0.64

1.6

2.3

mmol/l

1.2

—

(3045424) Erythrocytes [Presence] in Urine

314

1.25

0.63

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

129

1.40

0.63

1.1

1.2

u/ml

0.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.67

0.61

1.0

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.67

0.61

1.2

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

218

1.29

0.60

2.4

2.5

—

(3004616) Nuclear Ab [Presence] in Serum

227

1.28

0.60

1.4

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.59

0.0

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

529

5051

1.06

0.59

1.7

1.6

mmol/l

1.5

1.4

2.27

470

4197

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

113

0.62

0.58

1.4

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

115

0.61

0.57

7.3

6.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.46

0.56

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

181

0.72

0.52

1.0

u/ml

1.2

2.7

—

(40768793) Breast Pathology biopsy report

433

0.83

0.50

1.4

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.56

0.49

10.1

7.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.52

0.48

1.7

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

272

1.22

0.47

1.5

2.2

u/l

9595.8

2828.9

—

110

(3029075) Extractable nuclear Ab panel - Serum

1.46

0.46

1.1

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

155

1.29

0.46

1.3

1.1

—

55.6

—

(44813793)

117

0.68

0.46

1.1

—

(3005033) Fetal Nuchal fold Thickness US

117

0.68

0.46

1.3

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

118

0.68

0.45

1.3

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.43

0.45

1.5

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

121

0.66

0.45

1.3

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

139

1.30

0.43

1.9

1.6

—

(4024509)

175

1.26

0.43

1.8

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.52

0.41

1.0

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

380

0.84

0.41

1.4

1.5

pmol/l

179.1

281.8

0.72

374

(44806071)

0.00

0.40

0.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

250

1.20

0.40

1.2

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.33

0.40

1.0

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.37

0.40

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

475

0.86

0.40

1.4

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.43

0.39

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.37

0.38

1.1

miu/ml

783.9

1700.2

—

(40765096) Chromosome analysis panel by Banding

1.32

0.37

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.66

0.35

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1808

17943

1.05

0.34

4.6

mmol/l

4.6

4.7

2.18

1674

16555

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.67

0.32

1.5

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

174

1.21

0.31

1.6

1.2

nmol/l

1.7

1.5

0.32

153

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

220

2309

0.95

0.31

11.5

6.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

821

1.09

0.30

1.1

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1733

17206

1.04

0.27

4.2

4.1

mmol/l

1.4

1.3

8.41

1581

15663

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1793

17814

1.04

0.27

4.5

mmol/l

1.5

0.72

1649

16335

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1840

18296

1.04

0.26

5.2

5.1

mmol/l

2.7

2.8

4.59

1692

16786

(4146454)

213

0.84

0.25

2.6

2.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

103

1096

0.94

0.24

1.1

1.2

iu/ml

96.9

148.2

0.66

407

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.18

0.24

1.1

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

246

1.14

0.23

1.1

—

(4094501)

547

0.91

0.23

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

689

1.08

0.22

3.9

3.5

u/ml

33.8

2212.3

0.87

589

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.22

0.22

1.6

1.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

248

1.13

0.21

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.20

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

1.23

0.20

1.8

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.20

0.19

2.7

1.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.18

0.19

2.8

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.18

0.19

2.8

2.6

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

128

1.17

0.18

1.6

1.4

g/l

1.0

0.02

128

(44806420)

1.19

0.18

1.7

2.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.17

0.17

1.0

1.2

109.0

108.6

—

(3000330) Specific gravity of Urine by Test strip

904

1.05

0.17

5.1

3.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.76

0.17

1.2

1.1

—

0.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

207

1.11

0.15

1.3

1.2

mmol/l

8.2

7.6

0.37

154

(3013139) Helicobacter pylori Ag [Presence] in Stool

123

1185

1.04

0.14

1.2

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

518

1.06

0.14

1.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.81

0.13

10.3

13.4

nmol/l

741.9

809.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

133

1.13

0.12

1.5

pmol/l

119.5

63.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.11

0.09

1.4

1.1

—

21.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.09

0.09

1.7

1.4

ug/l

10.7

9.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

371

1.05

0.08

2.9

3.2

nmol/l

0.9

0.8

0.44

291

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.09

0.08

1.4

2.3

nmol/l

163.7

133.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.04

0.08

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

0.83

0.07

6.0

13.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.06

0.07

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.05

0.07

2.9

2.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

214

0.93

0.07

1.0

1.1

u/ml

0.0

1.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

129

1.09

0.05

1.0

ng/l

787.3

695.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

253

0.95

0.05

1.1

u/ml

0.3

1.7

1.63

102

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

122

1240

0.98

0.05

1.4

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

416

1.03

0.05

1.6

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

529

1.02

0.03

2.0

1.8

—

(4034850)

589

1.02

0.02

14.9

9.3

—

(4281824)

212

1.04

0.02

1.1

1.2

—

(3020491) Glucose [Moles/volume] in Blood

127

0.94

0.01

1.5

1.8

mmol/l

8.4

6.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

188

1871

1.01

0.01

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.06

0.01

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

449

1.00

0.00

5.0

4.4

—

(1002224) Polysomnography panel

709

1.00

0.00

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

386

1.01

0.00

1.1

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

218

1.01

0.00

1.1

u/ml

0.3

5.6

4.61

104

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.6

—

(3033799) Differential panel - Peritoneal fluid

0.87

0.00

1.3

2.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.91

0.00

1.2

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

1.00

0.00

1.2

1.6

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

3.8

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1745.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.6

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.90

0.00

1.0

1.4

—

(3044007) Cell count panel - Peritoneal fluid

1.00

0.00

1.7

2.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.92

0.00

1.2

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

1.00

0.00

1.3

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.6

—

7.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_OSTEONECROSIS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_OSTEONECROSIS	1.752 [1.53, 2.01]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.683

During the follow-up period (1.1.1998 — 31.12.2019), 1026 out of 4709 females with M13_OSTEONECROSIS died.

Males

Parameter	HR [95% CI]	p-value
M13_OSTEONECROSIS	2.658 [2.26, 3.13]	< 0.001
Birth year	0.981 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1006 out of 4055 males with M13_OSTEONECROSIS died.

Mortality risk

Mortality risk for people of age

years, who have M13_OSTEONECROSIS.

N-year risk	Females	Males
1	0.16%	0.449%
5	1.153%	2.442%
10	2.694%	6.224%
15	5.315%	11.334%
20	9.126%	18.844%

Relationships between endpoints

↥

Index endpoint: M13_OSTEONECROSIS – Osteonecrosis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Osteonecrosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints